Detection of Monocyte Chemoattractant Protein-1 Receptor Expression in Experimental Atherosclerotic Lesions: An Autoradiographic Study

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Circulation

• Publication date

  2001-07-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.104.2.203PMID 11447087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small is beautiful: Specialty imaging devices and the growth of nuclear cardiology

  2000cited by this paper
• Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99m DMP-444: A canine model.

  2000cited by this paper
• Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: A study based on four serial coronary arteriograms per year.

  1999cited by this paper
• Process of Progression of Coronary Artery Lesions From Mild or Moderate Stenosis to Moderate or Severe Stenosis

  1999cited by this paper
• Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates.

  1998cited by this paper
• Atlas of coronary artery disease

  1998cited by this paper
• Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells

  1998cited by this paper
• Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty.

  1997cited by this paper
• The site of acute myocardial infarction is related to the coronary territory of transient defects on prior myocardial perfusion imaging

  1996cited by this paper
• Relation between perfusion defects on stress technetium-99m sestamibi SPECT scintigraphy and the location of a subsequent acute myocardial infarction.

  1996cited by this paper
• Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction.

  1995cited by this paper
• Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.

  1995cited by this paper
• Findings of coronary angioscopy in angiographically normal coronary segments of patients with coronary artery disease.

  1995cited by this paper
• Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.

  1994cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Imaging of Thrombi With Tissue‐Type Plasminogen Activator Rendered Enzymatically Inactive and Conjugated to a Residualizing Label

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.

  1992cited by this paper
• Metabolic imaging with gallium-68- and indium-111-labeled low-density lipoprotein.

  1991cited by this paper
• Monocyte chemoattractant protein-1 in human atheromatous plaques.

  1991cited by this paper
• Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.

  1990cited by this paper
• Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients.

  1990cited by this paper
• Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin.

  1990cited by this paper
• Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE.

  1990cited by this paper
• Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes.

  1990cited by this paper
• Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE

  1989cited by this paper
• Indium-111-labeled platelet scintigraphy in carotid atherosclerosis.

  1989cited by this paper
• Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells.

  1989cited by this paper
• Identification of monocyte chemotactic activity produced by malignant cells.

  1989cited by this paper
• Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture.

  1988cited by this paper
• Selective accumulation of low density lipoproteins in damaged arterial wall.

  1983cited by this paper
• External imaging of human atherosclerosis.

  1983cited by this paper
• [Coronary artery disease].

  1980cited by this paper
• Scintigraphic Detection of Carotid Atherosclerosis with Indium‐111‐labeled Autologous Platelets

  1980cited by this paper
• Detection of atherosclerotic plaques in carotid arteries by the use of 123I-fibrinogen.

  1978cited by this paper
• Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets.

  1978cited by this paper
• EXPERIMENTAL ATHEROSCLEROSIS.

  1964cited by this paper

• Molecular imaging of cardiovascular disease: Current status and future perspective.

  2025cites this paper
• Association of Quantitative Coronary Artery Calcium Density Subtype Volumes With Major Adverse Cardiovascular Events

  2025cites this paper
• PET imaging of atherosclerosis: artificial intelligence applications and recent advancements

  2025cites this paper
• Clinical implications of circulating follistatin-like protein-1 in hemodialysis patients

  2023cites this paper
• Current Management of Highly Calcified Coronary Lesions: An Overview of the Current Status

  2023cites this paper
• Vulnerable Plaque Imaging.

  2022cites this paper
• The Integration of IVUS and OCT

  2019cites this paper
• Comparative effectiveness of different antiplatelet agents at reducing TNF‐driven inflammatory responses in a mouse model

  2019cites this paper
• Vascular Calcification: The Evolving Relationship of Vascular Calcification to Major Acute Coronary Events

  2019cites this paper
• Validation de modalités d’imagerie innovantes de l’athérosclérose par cathéter intravasculaire bimodal combinant fluorescence (NIRF) et ultrasons (IVUS) couplé à l’injection locale de sondes moléculaires in vivo ciblant ICAM-1 et le collagène

  2019cites this paper
• Molecular Imaging of Vulnerable Plaque.

  2018cites this paper
• Coronary Artery Calcification: From Mechanism to Molecular Imaging.

  2017cites this paper
• Rabbit models to study atherosclerosis and its complications - Transgenic vascular protein expression in vivo.

  2016cites this paper
• Atheroma and the inflammasome

  2015cites this paper
• Finding Calcium in Noncalcified Lesions: 18F-Fluoride Offers Insights into Atheroma Evolution

  2015cites this paper
• Integrated intravascular ultrasound and optical coherence tomography technology: a promising tool to identify vulnerable plaques [INVITED PAPER].

  2015cites this paper
• Atheroma and the inflammasome.

  2015cites this paper
• SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.

  2015cites this paper
• Clinical Feasibility and Monitoring of the Effects of Anti-inflammatory Therapy in Atherosclerosis

  2015cites this paper
• Modélisation, simulation et quantification de lésions athéromateuses en tomographie par émission de positons. (Numerical modeling, simulation and quantification of atheromatous lesions in positron emission tomography)

  2015cites this paper
• 18F-Fluoride as a marker of unstable atheroma – A Perspective

  2014cites this paper
• The effect of statins on cytokine regulated macrophage gene expression in atherosclerosis

  2014cites this paper
• The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders

  2014influential citation
• Molecular imaging of bacterial infections in vivo: the discrimination of infection from inflammation

  2014cites this paper
• Recent Advances in Visualizing Vulnerable Plaque: Focus on Noninvasive Molecular Imaging

  2014cites this paper
• The Therapeutic Role of Monocyte Chemoattractant Protein-1 in a Renal Tissue Engineering Strategy for Diabetic Patients

  2013cites this paper
• Novel molecular imaging of atherosclerosis with gallium-68-labeled apolipoprotein A-I mimetic peptide and positron emission tomography.

  2013cites this paper
• Caractérisation et imagerie moléculaire de la plaque d'athérome : études pré-cliniques

  2013cites this paper
• The vulnerable coronary plaque: update on imaging technologies

  2013cites this paper
• Nuclear medicine imaging of inflammatory diseases

  2013cites this paper
• DETECTION OF THE VULNERABLE ATHEROSCLEROTIC PLAQUE

  2012cites this paper
• Biological Imaging for the Diagnosis of Inflammatory Conditions

  2012cites this paper
• Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients

  2012cites this paper
• Progress in atherosclerotic plaque imaging.

  2012cites this paper
• Matrix metalloproteinases and vulnerable atheromatous plaque.

  2012cites this paper
• Intravascular atherosclerotic imaging with combined fluorescence and optical coherence tomography probe based on a double-clad fiber combiner.

  2012cites this paper
• Imaging of atherosclerosis.

  2011cites this paper
• Nanomedicine approaches in vascular disease: a review.

  2011cites this paper
• Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions.

  2011cites this paper
• Functional characterisation of orf virus chemokine binding protein

  2011cites this paper
• Cardiovascular molecular imaging: focus on clinical translation.

  2011cites this paper
• Extracellular Nucleotides Can Induce Chemokine (C-C motif) Ligand 2 Expression in Human Vascular Smooth Muscle Cells.

  2011cites this paper
• Molecular imaging in atherosclerosis

  2010cites this paper
• Molecular Imaging of Atherosclerotic Plaque with 64Cu-Labeled Natriuretic Peptide and PET

  2010cites this paper
• PET/SPECT imaging: from carotid vulnerability to brain viability.

  2010cites this paper
• Molecular imaging of inflammation/infection: nuclear medicine and optical imaging agents and methods.

  2010cites this paper
• Advanced carotid plaque imaging.

  2010cites this paper
• Multimodality Cardiovascular Molecular Imaging Technology

  2010cites this paper
• Radionuclide Imaging of Inflammation in Atheroma

  2010cites this paper
• Chapter 3 – Role of Intact Biological Models for Evaluation of Radiotracers

  2010cites this paper
• Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis : an overview

  2010cites this paper
• Gadolinium-Enhanced Magnetic Resonance Imaging of Atherosclerotic Plaques in Comparison with Histopathology: An In Vivo Study in Aorta of Rabbits

  2009cites this paper
• Gamma imaging of atherosclerotic plaques

  2009influential citation
• Imagerie moléculaire de la plaque d’athérome vulnérable. Évaluation préclinique et clinique de traceurs radioactifs

  2009cites this paper
• Emergence of targeted molecular imaging in atherosclerotic cardiovascular disease

  2009cites this paper
• Functional imaging of inflammatory diseases using nuclear medicine techniques.

  2009cites this paper
• Imaging of the Vulnerable Atherosclerotic Plaque. Pre-Clinical Evaluation of PET Tracers for Vascular Inflammation

  2009cites this paper
• Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview.

  2009cites this paper
• Radiotracer imaging of atherosclerotic plaque biology.

  2009cites this paper
• Emergence of targeted molecular imaging in atherosclerotic

  2009cites this paper
• Molecular imaging will replace perfusion imaging: The impossible dream

  2008cites this paper
• Application of PET/SPECT imaging in vascular disease.

  2008cites this paper
• Nuclear Cardiac Stress Testing in the Era of Molecular Medicine*

  2008cites this paper
• Radionuclide imaging: a molecular key to the atherosclerotic plaque.

  2008cites this paper
• Cilostazol attenuates MCP‐1 and MMP‐9 expression in vivo in LPS‐administrated balloon‐injured rabbit aorta and in vitro in LPS‐treated monocytic THP‐1 cells

  2008cites this paper
• Molecular imaging of atherosclerosis

  2008cites this paper
• Nuclear medicine applications in molecular imaging: 2007 update.

  2007cites this paper
• Where is the trace? Molecular imaging of vulnerable atherosclerotic plaques.

  2007cites this paper
• Radiolabeled Monocyte Chemotactic Protein 1 for the Detection of Inflammation in Experimental Atherosclerosis

  2007cites this paper
• Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p

  2007cites this paper
• Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE−/− mice

  2007cites this paper
• Molecular imaging of vulnerable plaque by cardiac magnetic resonance imaging.

  2007cites this paper
• Chemokines at large: In-vivo mechanisms of their transport, presentation and clearance

  2007cites this paper
• Radionuclide Techniques for Identifying Vulnerable Plaque

  2007cites this paper
• Biomarkers of obesity and subsequent cardiovascular events.

  2007cites this paper
• Imaging in Carotid Artery Stenosis: Prospects to the Future

  2007cites this paper
• Imaging techniques for the vulnerable coronary plaque Metodiche di imaging per la placca vulnerabile coronarica

  2007cites this paper
• Radionuclide Techniques for Identifying Vulnerable Plaque

  2007cites this paper
• Cardiovascular molecular imaging of apoptosis

  2007cites this paper
• Imaging techniques for the vulnerable coronary plaque

  2007cites this paper
• Cardiovascular Molecular Imaging 1

  2007cites this paper
• Atheroma roulette

  2007cites this paper
• Where Is the Trace? Molecular Imaging of Vulnerable Atherosclerotic Plaques

  2007cites this paper
• Molecular Imaging of Vulnerable Plaque by Cardiac Magnetic Resonance Imaging

  2007cites this paper
• Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions

  2007cites this paper
• Cardiovascular molecular imaging.

  2007cites this paper
• “Tolerance” assays: the physician's guide to safe weaning of immunosuppression?

  2006cites this paper
• EVALUATION DE NOUVEAUX RADIOPHARMACEUTIQUES Synthèse, évaluation, et biodistribution de nouveaux radioligands peptidiques de VCAM-1 et avb3

  2006cites this paper
• Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis.

  2006cites this paper
• Intravascular radiation detectors for the detection of vulnerable atheroma.

  2006cites this paper
• Identification of interleukin-2 for imaging atherosclerotic inflammation

  2006cites this paper
• Molecular imaging of vulnerable atherosclerotic plaques.

  2006cites this paper
• The pathobiology of the vessel wall: Implications for imaging

  2006cites this paper
• Fluorodeoxyglucose and calcium uptake in the vascular wall: Clinically relevant or sugar-coated pill?

  2006cites this paper
• What Is the Role of Molecular Imaging in the Management of Cardiac Disorders

  2006cites this paper
• Radionuclide imaging for the detection of inflammation in vulnerable plaques.

  2006cites this paper
• Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology.

  2006cites this paper
• Regulació de la producció de gelatinases (MMP2 i MMP9) pels limfòcits. Implicació en malalties inflamatòries i

  2006cites this paper
• Atherosclerosis imaging on the molecular level

  2006cites this paper
• Vulnerable plaque: Definition, detection, treatment, and future implications

  2005cites this paper